πŸ‡ΊπŸ‡Έ FDA
Patent

US 8859498

Targeted therapeutic proteins

granted A61KA61K2039/505A61K2039/515

Quick answer

US patent 8859498 (Targeted therapeutic proteins) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K2039/515, A61K35/12, A61K35/54